Research

Fitness & Body

How your genes influence muscle performance, bone density, injury risk, and joint health

See your personal results for Fitness & Body

Upload your DNA data and find out which variants you carry across all 30 SNPs in this category.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

Genetic Variants (30)

rs1042713

(ADRB2 Arg16Gly)

Beta-2 adrenergic receptor variant affecting receptor downregulation, exercise capacity, beta-agonist drug response, and cardiovascular function

rs1053049

(PPARD 3'UTR variant)

3'UTR variant in PPARD that acts as the third tag in the elite athlete haplotype (rs2267668/rs2016520/rs1053049); TC carriers show enhanced skeletal muscle glucose uptake and insulin sensitivity; the A/C/C haplotype containing this C allele is dramatically underrepresented in elite athletes

rs10980705

(LPAR1)

Upstream regulatory variant that increases LPAR1 transcriptional activity in synovial cells, associated with elevated knee osteoarthritis susceptibility in Japanese populations

rs1108086

(FTO FTO Intron 8 T>C)

An FTO intron-8 variant in the same haplotype block as rs1420318, with emerging associations with bone mineral density and alcohol dependence susceptibility; distinct from the primary intron-1 obesity cluster

rs11842874

(MCF2L)

Intronic variant in MCF2L that acts as a synovial eQTL — A allele carriers have higher MCF2L expression in joint tissue and elevated osteoarthritis risk across large joints

rs12722

(COL5A1 C/T 3'UTR)

Collagen fibril assembly variant linked to soft tissue injury risk

rs1420318

(FTO)

FTO intron 8 variant associated with nominal spine bone mineral density effects and alcohol dependence susceptibility; low LD with the rs9939609 obesity cluster

rs143383

(GDF5 C/T)

Regulatory variant in GDF5 affecting cartilage development and osteoarthritis risk in knees, hips, and spine

rs1572312

(NFIA-AS2)

Long non-coding RNA regulating erythropoiesis, influencing hemoglobin levels and oxygen transport capacity in endurance athletes

rs17602729

(AMPD1 C34T (Q12X))

Enzyme critical for energy production during high-intensity exercise; deficiency reduces sprint and power performance

rs1800012

(COL1A1 Sp1 Binding Site)

Sp1 transcription factor binding site polymorphism affecting collagen production, bone mineral density, and osteoporotic fracture risk

rs1800764

(ACE Promoter T>C)

Upstream promoter-region ACE variant on a separate LD block from the I/D polymorphism — the C allele is associated with young-onset hypertension

rs1801252

(ADRB1 Ser49Gly)

Beta-1 adrenergic receptor variant at position 49 affecting receptor downregulation kinetics, resting heart rate, heart failure prognosis, and endurance exercise capacity

rs1805086

(MSTN K153R)

Affects myostatin's ability to limit muscle growth, influencing muscle mass and strength response to training

rs1815739

(ACTN3 R577X)

Determines presence of alpha-actinin-3 protein in fast-twitch muscle fibers, influencing sprint/power vs endurance capacity

rs2228001

(XPC Lys939Gln)

Missense variant in the DNA damage recognition gene XPC that reduces global-genome nucleotide excision repair capacity, affecting recovery from UV-induced damage, exercise-generated oxidative DNA lesions, and environmental carcinogen exposure

rs243865

(MMP2 C-1306T)

Promoter polymorphism that disrupts an Sp1-binding site and reduces MMP-2 enzyme production, affecting extracellular matrix remodeling in connective tissue and adipose tissue

rs28937900

(FKRP L276I)

The most common pathogenic mutation in FKRP causing limb-girdle muscular dystrophy R9 (LGMD R9) in European populations; homozygous carriers develop progressive proximal muscle weakness

rs2908004

(WNT16 Gly82Arg)

Missense variant in WNT16 that substitutes glycine for arginine at position 82, reducing cortical bone mineral density and increasing fracture risk

rs35767

(IGF1 C-1245T)

Promoter variant affecting circulating IGF-1 levels and athletic performance potential

rs3736228

(LRP5 A1330V)

Wnt signaling co-receptor variant affecting bone mineral density and fracture risk

rs3801387

(WNT16)

Intronic variant affecting cortical bone thickness, bone mineral density, and fracture risk

rs4235308

(PPARGC1A)

Intronic variant in the PGC-1alpha gene linked to population-specific type 2 diabetes risk and mitochondrial biogenesis regulation

rs4988321

(LRP5 Val667Met)

Missense variant in LRP5 that substitutes valine for methionine at position 667, modestly reducing Wnt signaling and lowering bone mineral density — particularly in physically active individuals

rs62623713

(SYPL2 E99G)

Low-frequency missense variant in SYPL2 associated with morbid obesity susceptibility

rs6902123

(PPARD)

Intronic PPARD variant that independently impairs hepatic fat mobilization during lifestyle intervention; C-allele carriers show smaller reductions in liver fat regardless of how much total body fat they lose, linking this locus specifically to ectopic liver lipid regulation rather than general adiposity

rs699

(AGT M235T)

Angiotensinogen level variant affecting blood pressure, sodium sensitivity, and cardiovascular adaptation to exercise

rs7181866

(GABPB1)

Intronic variant in the mitochondrial biogenesis regulator NRF2, associated with endurance athletic performance and intermittent exercise capacity

rs8192678

(PPARGC1A Gly482Ser)

Master mitochondrial biogenesis regulator — Ser482 variant reduces PGC-1alpha transcriptional activity, impairing mitochondrial production, aerobic capacity, and metabolic adaptation

rs9594759

(TNFSF11)

Regulatory variant in the RANKL gene affecting bone mineral density and osteoporotic fracture risk